Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health www.cancer.gov
CCR - For Our Staff| Home |

Our Science – Terunuma Website

Atsushi Terunuma, M.D., Ph.D.

Selected Publications
1)  Terunuma A, Cross JW, Dyke M, Kapoor V, Telford WG, Vogel JC.
Behavior of human foreskin keratinocytes expressing a hair follicle stem cell marker CD200.
J. Invest. Dermatol. 128: 1332-4, 2008. [Journal]
2)  Terunuma A, Kapoor V, Yee C, Telford WG, Udey MC, Vogel JC.
Stem Cell Activity of Human Side Population and {alpha}6 Integrin-Bright Keratinocytes Defined by a Quantitative In Vivo Assay.
Stem Cells. 25: 664-9, 2007. [Journal]
3)  Ohyama M, Terunuma A, Tock CL, Radonovich MF, Pise-Masison CA, Hopping SB, Brady JN, Udey MC, Vogel JC.
Characterization and isolation of stem cell-enriched human hair follicle bulge cells.
J Clin Invest. 116: 249-60, 2006. [Journal]
4)  Blonder J, Conrads TP, Yu LR, Terunuma A, Janini GM, Issaq HJ, Vogel JC, Veenstra TD.
A detergent- and cyanogen bromide-free method for integral membrane proteomics: application to Halobacterium purple membranes and the human epidermal membrane proteome.
Proteomics. 4: 31-45, 2004. [Journal]
5)  Blonder J, Terunuma A, Conrads TP, Chan KC, Yee C, Lucas DA, Schaefer CF, Yu LR, Issaq HJ, Veenstra TD, Vogel JC.
A proteomic characterization of the plasma membrane of human epidermis by high-throughput mass spectrometry.
J Invest Dermatol. 123: 691-9, 2004. [Journal]
6)  Terunuma A, Shaya MB, Udey MC, Vogel JC.
An in vivo competitive repopulation assay system to evaluate human keratinocyte stem cells.
J Invest Dermatol. 123: 993-5, 2004. [Journal]
7)  Terunuma A, Ye J, Emmert S, Khan SG, Kraemer KH, Vogel JC.
Ultraviolet light selection assay to optimize oligonucleotide correction of mutations in endogenous xeroderma pigmentosum genes.
Gene Ther. 11: 1729-34, 2004. [Journal]
8)  Hoang VM, Conrads TP, Veenstra TD, Blonder J, Terunuma A, Vogel JC, Fisher RJ.
Quantitative proteomics employing primary amine affinity tags.
J Biomol Tech. 14: 216-23, 2003. [Journal]
9)  Terunuma A, Jackson KL, Kapoor V, Telford WG, Vogel JC.
Side population keratinocytes resembling bone marrow side population stem cells are distinct from label-retaining keratinocyte stem cells.
J Invest Dermatol. 121: 1095-103, 2003. [Journal]
10)  Kuhn U, Terunuma A, Pfutzner W, Foster RA, Vogel JC.
In vivo assessment of gene delivery to keratinocytes by lentiviral vectors.
J Virol. 76: 1496-504, 2002. [Journal]
11)  Pfutzner W, Terunuma A, Tock CL, Snead EK, Kolodka TM, Gottesman MM, Taichman L, Vogel JC.
Topical colchicine selection of keratinocytes transduced with the multidrug resistance gene (MDR1) can sustain and enhance transgene expression in vivo.
Proc Natl Acad Sci U S A. 99: 13096-101, 2002. [Journal]
12)  Terunuma A, Aiba S, Tagami H.
Cytokine mRNA profiles in cultured human skin component cells exposed to various chemicals: a simulation model of epicutaneous stimuli induced by skin barrier perturbation in comparison with that due to exposure to haptens or irritant.
J Dermatol Sci. 26: 85-93, 2001. [Journal]
13)  Terui T, Takahashi K, Funayama M, Terunuma A, Ozawa M, Sasai S, Tagami H.
Occurrence of neutrophils and activated Th1 cells in UVB-induced erythema.
Acta Derm Venereol. 81: 8-13, 2001. [Journal]
14)  Terunuma A, Watabe A, Kato T, Tagami H.
Coexistence of vitiligo and sarcoidosis in a patient with circulating autoantibodies.
Int J Dermatol. 39: 551-3, 2000. [Journal]
15)  Terui T, Funayama M, Terunuma A, Takahashi K, Tagami H.
Ultraviolet B radiation exerts enhancing effects on the production of a complement component, C3, by interferon-gamma-stimulated cultured human epidermal keratinocytes, in contrast to photochemotherapy and ultraviolet A radiation that show suppressive effects.
Br J Dermatol. 142: 660-8, 2000. [Journal]
16)  Komatsu H, Terunuma A, Tabata N, Tagami H.
Mycobacterium avium infection of the skin associated with lichen scrofulosorum: report of three cases.
Br J Dermatol. 141: 554-7, 1999. [Journal]
17)  Terunuma A, Shiba K, Noda T.
A novel genetic system to isolate a dominant negative effector on DNA-binding activity of Oct-2.
Nucleic Acids Res. 25: 1984-90, 1997. [Journal]
18)  Aiba S, Terunuma A, Manome H, Tagami H.
Dendritic cells differently respond to haptens and irritants by their production of cytokines and expression of co-stimulatory molecules.
Eur J Immunol. 27: 3031-8, 1997. [Journal]
19)  Terunuma A, Hashimoto-Kumasaka K, Hirasawa Y, Ogasawara T, Atsumi M.
Multiple skin metastases revealing an esophageal adenocarcinoma.
European Journal of Dermatology. 3: 173-174, 1997. [Journal]
20)  Kudoh K, Kamei E, Terunuma A, Nakagawa S, Tagami H.
Successful treatment of cutaneous sporotrichosis with terbinafine.
Journal of Dermatological Treatment. 7: 33-35, 1996. [Journal]
21)  Terunuma A, Shiba K, Noda T.
Genetic isolation of a human cDNA clone that trans-dominantly inhibits the DNA-binding activity of Oct-2 protein.
Protein Engineering. 8: 77, 1995. [Journal]
22)  Terunuma A, Takahashi K, Sakakibara A, Aiba S, Tagami H.
Annular psoriasiform eruption with lymphocytic infiltration of the epidermis: a variant of acute psoriasis?.
Dermatology. 185: 156-9, 1992. [Journal]

This page was last updated on 11/24/2008.